investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Generation of Highly Avid Anti-Tumor CTL for Optimal Adoptive Immunotherapy
Naoto Hirano
0 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Naoto Hirano
University Health Network
Toronto, Canada
Related projects
Georges Mer
Post-translational Modifications in DNA Damage Response: a Structural Perspective
All cancers but non-melanoma skin cancer
Mary Mcbride
Phase-Specific and Lifetime Medical Costs of Care for Childhood Cancer in British Columbia and Ontario
All cancers but non-melanoma skin cancer
Pediatric oncology or childhood cancer
Paul Randazzo
Regulation of ADP-Ribosylation Factor
All cancers but non-melanoma skin cancer
Dennis Klinman
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
All cancers but non-melanoma skin cancer
Sankar Mitra
Repair Co-ordination of Radiation-Induced Clustered Damage In Mammalian Genomes
All cancers but non-melanoma skin cancer
Radiation Oncology
Stefan Taubert
CRC Tier 2 - Studying Mediator Components
All cancers but non-melanoma skin cancer
Daniela Salvemini
A3AR Agonists to Prevent Chemotherapy-Induced Painful Peripheral Neuropathy
All cancers but non-melanoma skin cancer
Mark Lathrop
CRC Tier 1 - New research programme to understand the genetic causes of human diseases such as cancer, asthma and heart disease
All cancers but non-melanoma skin cancer
Xinhua Ji
Biomolecular Structure and Mechanism, Structure-Based Drug Design
All cancers but non-melanoma skin cancer